Plexus Corp. (NASDAQ:PLXS – Get Free Report) CEO Todd Kelsey sold 1,000 shares of Plexus stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $290.00, for a total value of $290,000.00. Following the transaction, the chief executive officer owned 70,388 shares in the company, valued at $20,412,520. This trade represents a 1.40% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.
Plexus Price Performance
NASDAQ:PLXS traded down $3.20 on Thursday, reaching $284.35. 409,342 shares of the company’s stock traded hands, compared to its average volume of 338,867. The company has a quick ratio of 0.74, a current ratio of 1.54 and a debt-to-equity ratio of 0.06. The stock has a 50-day simple moving average of $242.60 and a 200-day simple moving average of $197.77. The firm has a market cap of $7.61 billion, a PE ratio of 41.57 and a beta of 0.89. Plexus Corp. has a 12 month low of $115.35 and a 12 month high of $292.33.
Plexus (NASDAQ:PLXS – Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The technology company reported $2.05 EPS for the quarter, beating analysts’ consensus estimates of $1.87 by $0.18. The business had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.13 billion. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The business’s quarterly revenue was up 18.7% on a year-over-year basis. During the same period last year, the firm earned $1.66 earnings per share. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. Equities research analysts forecast that Plexus Corp. will post 5.98 earnings per share for the current year.
Institutional Investors Weigh In On Plexus
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the company. Benchmark restated a “buy” rating and issued a $220.00 price target on shares of Plexus in a research note on Monday, March 16th. Needham & Company LLC boosted their target price on shares of Plexus from $285.00 to $310.00 and gave the stock a “buy” rating in a report on Monday. Zacks Research downgraded shares of Plexus from a “hold” rating to a “strong sell” rating in a report on Wednesday, May 20th. Raymond James Financial reissued an “outperform” rating and issued a $275.00 target price on shares of Plexus in a report on Thursday, April 30th. Finally, Weiss Ratings raised shares of Plexus from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, May 11th. Five research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $238.33.
View Our Latest Stock Analysis on PLXS
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Read More
- Five stocks we like better than Plexus
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
